Group Management

Frederic Vanderhaegen 

CEO and President

The Board of Directors appointed Frederic Vanderhaegen as CEO and President of Biotage, effective September 16th, 2024. Before this appointment, Frederic was the General Manager and Executive Vice President for Europe at Avantor, where he also led the global portfolio for the life sciences business, sourcing, and commercial excellence teams. He has previously held various senior leadership positions at companies such as Ortho Clinical Diagnostics, Danaher, Tecan, and Millipore. Frederic holds a degree in Biochemical Engineering from Haute Ecole Lucia Debroeckere, a degree in Chemical and Agricultural Engineering from Université Libre de Bruxelles, and an MBA from the Open University.

Andrew Kellett

Chief Financial Officer

Andrew Kellett is the CFO at Biotage as of September 25th 2023.  Andrew has a strong track record in the financial and operational leadership of international science and technology growth companies. Most recently, Andrew was the CFO of Technetix Group, an international technology business. His previous roles have included CFO of Genetix PLC, a publicly listed business, here he played a key role in the growth, transformation, and successful sale of the company to the Danaher Corporation. He also held CFO positions at Cmed Group, an international CRO and the Global Controller of the Clinical Trials and Pharmaceutical Development business of Quest Diagnostics, a fortune 500 company. Andrew is a Chartered Accountant having qualified with Coopers and Lybrand.